Skip to main content
NCBI home page
Environmental Health Perspectives logoLink to Environmental Health Perspectives
. 1993 Mar;99:99–105. doi: 10.1289/ehp.939999

Does aflatoxin exposure in the United Kingdom constitute a cancer risk?

J C Harrison 1, M Carvajal 1, R C Garner 1
PMCID: PMC1567057  PMID: 8319666

Abstract

Although the aflatoxins were discovered more than 30 years ago, there is still considerable controversy surrounding their human health effects. Most countries have introduced legislation to control the level of aflatoxins in food, but it is not known if these permitted levels still pose a significant cancer risk. Furthermore, it is unlikely that all the sources of human aflatoxin exposure have been discovered, nor if the liver is the only, or indeed, major target organ for aflatoxin-induced cancer in man. In our laboratory we have used both immunological and HPLC methods to examine human DNA from a variety of tissues and organs to identify and quantify aflatoxin DNA-adducts. We have already detected aflatoxin B1 (AFB1)-DNA adducts in formalin-fixed tissue from an acute poisoning incident in Southeast Asia. Here we have examined human colon and rectum DNA from normal and tumorous tissue obtained from cancer patients and colon, liver, pancreas, breast, and cervix DNA from autopsy specimens. AFB1-DNA adducts were detected in all tissue types examined and ranged from 0-60 adducts/10(6) nucleotides. Where sample size allowed, the adduct levels were confirmed by HPLC analysis. Tumor tissues tended to have higher adduct levels than normal tissue from the same individual, and levels generally increased with patient age. In samples analyzed by HPLC, the adducts present had the chromatographic properties of [8,9-dihydro-8-(N5-formyl)-2',5',6'-triamino-4'-oxo-(N5-pyramidyl) -9- hydroxy-aflatoxin B1, the ring-opened form of the AFB1-guanine adduct.(ABSTRACT TRUNCATED AT 250 WORDS)

Full text

PDF
99

Selected References

These references are in PubMed. This may not be the complete list of references from this article.

  1. Abeywickrama K., Bean G. A. Toxigenic Aspergillus flavus and aflatoxins in Sri Lankan medicinal plant material. Mycopathologia. 1991 Mar;113(3):187–190. doi: 10.1007/BF00436129. [DOI] [PubMed] [Google Scholar]
  2. Alpert M. E., Hutt M. S., Wogan G. N., Davidson C. S. Association between aflatoxin content of food and hepatoma frequency in Uganda. Cancer. 1971 Jul;28(1):253–260. doi: 10.1002/1097-0142(197107)28:1<253::aid-cncr2820280151>3.0.co;2-g. [DOI] [PubMed] [Google Scholar]
  3. Autrup H., Bradley K. A., Shamsuddin A. K., Wakhisi J., Wasunna A. Detection of putative adduct with fluorescence characteristics identical to 2,3-dihydro-2-(7'-guanyl)-3-hydroxyaflatoxin B1 in human urine collected in Murang'a district, Kenya. Carcinogenesis. 1983 Sep;4(9):1193–1195. doi: 10.1093/carcin/4.9.1193. [DOI] [PubMed] [Google Scholar]
  4. Autrup H., Essigmann J. M., Croy R. G., Trump B. F., Wogan G. N., Harris C. C. Metabolism of aflatoxin B1 and identification of the major aflatoxin B1-DNA adducts formed in cultured human bronchus and colon. Cancer Res. 1979 Mar;39(3):694–698. [PubMed] [Google Scholar]
  5. Autrup H., Seremet T., Wakhisi J., Wasunna A. Aflatoxin exposure measured by urinary excretion of aflatoxin B1-guanine adduct and hepatitis B virus infection in areas with different liver cancer incidence in Kenya. Cancer Res. 1987 Jul 1;47(13):3430–3433. [PubMed] [Google Scholar]
  6. Bailey G. S., Williams D. E., Wilcox J. S., Loveland P. M., Coulombe R. A., Hendricks J. D. Aflatoxin B1 carcinogenesis and its relation to DNA adduct formation and adduct persistence in sensitive and resistant salmonid fish. Carcinogenesis. 1988 Nov;9(11):1919–1926. doi: 10.1093/carcin/9.11.1919. [DOI] [PubMed] [Google Scholar]
  7. Bressac B., Kew M., Wands J., Ozturk M. Selective G to T mutations of p53 gene in hepatocellular carcinoma from southern Africa. Nature. 1991 Apr 4;350(6317):429–431. doi: 10.1038/350429a0. [DOI] [PubMed] [Google Scholar]
  8. Buss P., Caviezel M., Lutz W. K. Linear dose-response relationship for DNA adducts in rat liver from chronic exposure to aflatoxin B1. Carcinogenesis. 1990 Dec;11(12):2133–2135. doi: 10.1093/carcin/11.12.2133. [DOI] [PubMed] [Google Scholar]
  9. Campbell T. C., Chen J. S., Liu C. B., Li J. Y., Parpia B. Nonassociation of aflatoxin with primary liver cancer in a cross-sectional ecological survey in the People's Republic of China. Cancer Res. 1990 Nov 1;50(21):6882–6893. [PubMed] [Google Scholar]
  10. Campbell T. C., Stoloff L. Implication of mycotoxins for human health. J Agric Food Chem. 1974 Nov-Dec;22(6):1006–1015. doi: 10.1021/jf60196a016. [DOI] [PubMed] [Google Scholar]
  11. Chaves-Carballo E., Ellefson R. D., Gomez M. R. An aflatoxin in the liver of a patient with Reye-Johnson syndrome. Mayo Clin Proc. 1976 Jan;51(1):48–50. [PubMed] [Google Scholar]
  12. Coles B., Ketterer B. The role of glutathione and glutathione transferases in chemical carcinogenesis. Crit Rev Biochem Mol Biol. 1990;25(1):47–70. doi: 10.3109/10409239009090605. [DOI] [PubMed] [Google Scholar]
  13. Croy R. G., Essigmann J. M., Reinhold V. N., Wogan G. N. Identification of the principal aflatoxin B1-DNA adduct formed in vivo in rat liver. Proc Natl Acad Sci U S A. 1978 Apr;75(4):1745–1749. doi: 10.1073/pnas.75.4.1745. [DOI] [PMC free article] [PubMed] [Google Scholar]
  14. Cuzick J., Routledge M. N., Jenkins D., Garner R. C. DNA adducts in different tissues of smokers and non-smokers. Int J Cancer. 1990 Apr 15;45(4):673–678. doi: 10.1002/ijc.2910450417. [DOI] [PubMed] [Google Scholar]
  15. Dalcero A., Chulze S., Etcheverry M., Farnochi C., Varsavsky E. Aflatoxins in sunflower seeds: influence of Alternaria alternata on aflatoxin production by Aspergillus parasiticus. Mycopathologia. 1989 Oct;108(1):31–35. doi: 10.1007/BF00436781. [DOI] [PubMed] [Google Scholar]
  16. Dashwood R. H., Arbogast D. N., Fong A. T., Pereira C., Hendricks J. D., Bailey G. S. Quantitative inter-relationships between aflatoxin B1 carcinogen dose, indole-3-carbinol anti-carcinogen dose, target organ DNA adduction and final tumor response. Carcinogenesis. 1989 Jan;10(1):175–181. doi: 10.1093/carcin/10.1.175. [DOI] [PubMed] [Google Scholar]
  17. Dvorackova I., Stora C., Ayraud N. Evidence of aflatoxin B1 in two cases of lung cancer in man. J Cancer Res Clin Oncol. 1981;100(2):221–224. doi: 10.1007/BF00403368. [DOI] [PMC free article] [PubMed] [Google Scholar]
  18. Dvorácková I., Kusák V., Veselý D., Veselá J., Nesnídal P. Aflatoxin and encephalopathy with fatty degeneration of viscera (Reye). Ann Nutr Aliment. 1977;31(4-6):977–989. [PubMed] [Google Scholar]
  19. Forrester L. M., Hayes J. D., Millis R., Barnes D., Harris A. L., Schlager J. J., Powis G., Wolf C. R. Expression of glutathione S-transferases and cytochrome P450 in normal and tumor breast tissue. Carcinogenesis. 1990 Dec;11(12):2163–2170. doi: 10.1093/carcin/11.12.2163. [DOI] [PubMed] [Google Scholar]
  20. Gan L. S., Skipper P. L., Peng X. C., Groopman J. D., Chen J. S., Wogan G. N., Tannenbaum S. R. Serum albumin adducts in the molecular epidemiology of aflatoxin carcinogenesis: correlation with aflatoxin B1 intake and urinary excretion of aflatoxin M1. Carcinogenesis. 1988 Jul;9(7):1323–1325. doi: 10.1093/carcin/9.7.1323. [DOI] [PubMed] [Google Scholar]
  21. Garner R. C., Martin C. N., Smith J. R., Coles B. F., Tolson M. R. Comparison of aflatoxin B1 and aflatoxin G1 binding to cellular macromolecules in vitro, in vivo and after peracid oxidation; characterisation of the major nucleic acid adducts. Chem Biol Interact. 1979 Jun;26(1):57–73. doi: 10.1016/0009-2797(79)90093-0. [DOI] [PubMed] [Google Scholar]
  22. Gupta R. C. Nonrandom binding of the carcinogen N-hydroxy-2-acetylaminofluorene to repetitive sequences of rat liver DNA in vivo. Proc Natl Acad Sci U S A. 1984 Nov;81(22):6943–6947. doi: 10.1073/pnas.81.22.6943. [DOI] [PMC free article] [PubMed] [Google Scholar]
  23. Harris C. C., Sun T. Multifactoral etiology of human liver cancer. Carcinogenesis. 1984 Jun;5(6):697–701. doi: 10.1093/carcin/5.6.697. [DOI] [PubMed] [Google Scholar]
  24. Harrison J. C., Garner R. C. Immunological and HPLC detection of aflatoxin adducts in human tissues after an acute poisoning incident in S.E. Asia. Carcinogenesis. 1991 Apr;12(4):741–743. doi: 10.1093/carcin/12.4.741. [DOI] [PubMed] [Google Scholar]
  25. Hendrickse R. G., Maxwell S. M., Young R. Aflatoxins and heroin. BMJ. 1989 Aug 19;299(6697):492–493. doi: 10.1136/bmj.299.6697.492. [DOI] [PMC free article] [PubMed] [Google Scholar]
  26. Hertzog P. J., Smith J. R., Garner R. C. Characterisation of the imidazole ring-opened forms of trans-8,9-dihydro-8,9-dihydro-8-(7-guanyl)9-hydroxy aflatoxin B1. Carcinogenesis. 1982;3(6):723–725. doi: 10.1093/carcin/3.6.723. [DOI] [PubMed] [Google Scholar]
  27. Hsieh L. L., Hsu S. W., Chen D. S., Santella R. M. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer Res. 1988 Nov 15;48(22):6328–6331. [PubMed] [Google Scholar]
  28. Hsieh L. L., Hsu S. W., Chen D. S., Santella R. M. Immunological detection of aflatoxin B1-DNA adducts formed in vivo. Cancer Res. 1988 Nov 15;48(22):6328–6331. [PubMed] [Google Scholar]
  29. Lee H. S., Sarosi I., Vyas G. N. Aflatoxin B1 formamidopyrimidine adducts in human hepatocarcinogenesis: a preliminary report. Gastroenterology. 1989 Nov;97(5):1281–1287. doi: 10.1016/0016-5085(89)91700-9. [DOI] [PubMed] [Google Scholar]
  30. Newberne P. M., Wogan G. N. Sequential morphologic changes in aflatoxin B carcinogenesis in the rat. Cancer Res. 1968 Apr;28(4):770–781. [PubMed] [Google Scholar]
  31. Peers F. G., Gilman G. A., Linsell C. A. Dietary aflatoxins and human liver cancer. A study in Swaziland. Int J Cancer. 1976 Feb 15;17(2):167–176. doi: 10.1002/ijc.2910170204. [DOI] [PubMed] [Google Scholar]
  32. Peers F. G., Linsell C. A. Dietary aflatoxins and liver cancer--a population based study in Kenya. Br J Cancer. 1973 Jun;27(6):473–484. doi: 10.1038/bjc.1973.60. [DOI] [PMC free article] [PubMed] [Google Scholar]
  33. Phillips D. H., Hewer A., Martin C. N., Garner R. C., King M. M. Correlation of DNA adduct levels in human lung with cigarette smoking. Nature. 1988 Dec 22;336(6201):790–792. doi: 10.1038/336790a0. [DOI] [PubMed] [Google Scholar]
  34. Phillips D. L., Yourtee D. M., Searles S. Presence of aflatoxin B1 in human liver in the United States. Toxicol Appl Pharmacol. 1976 May;36(2):403–406. doi: 10.1016/0041-008x(76)90018-1. [DOI] [PubMed] [Google Scholar]
  35. Ramsdell H. S., Eaton D. L. Species susceptibility to aflatoxin B1 carcinogenesis: comparative kinetics of microsomal biotransformation. Cancer Res. 1990 Feb 1;50(3):615–620. [PubMed] [Google Scholar]
  36. Rasić J. L., Skrinjar M., Markov S. Decrease of aflatoxin B1 in yoghurt and acidified milks. Mycopathologia. 1991 Feb;113(2):117–119. doi: 10.1007/BF00442421. [DOI] [PubMed] [Google Scholar]
  37. Sabbioni G., Ambs S., Wogan G. N., Groopman J. D. The aflatoxin-lysine adduct quantified by high-performance liquid chromatography from human serum albumin samples. Carcinogenesis. 1990 Nov;11(11):2063–2066. doi: 10.1093/carcin/11.11.2063. [DOI] [PubMed] [Google Scholar]
  38. Sharman M., Patey A. L., Bloomfield D. A., Gilbert J. Surveillance and control of aflatoxin contamination of dried figs and fig paste imported into the United Kingdom. Food Addit Contam. 1991 May-Jun;8(3):299–304. doi: 10.1080/02652039109373979. [DOI] [PubMed] [Google Scholar]
  39. Stoloff L. Aflatoxin is not a probably human carcinogen: the published evidence is sufficient. Regul Toxicol Pharmacol. 1989 Dec;10(3):272–283. doi: 10.1016/0273-2300(89)90054-8. [DOI] [PubMed] [Google Scholar]
  40. Van Egmond H. P. Current situation on regulations for mycotoxins. Overview of tolerances and status of standard methods of sampling and analysis. Food Addit Contam. 1989 Apr-Jun;6(2):139–188. doi: 10.1080/02652038909373773. [DOI] [PubMed] [Google Scholar]
  41. Van Rensburg S. J., van der Watt J. J., Purchase I. F., Pereira Coutinho L., Markham R. Primary liver cancer rate and aflatoxin intake in a high cancer area. S Afr Med J. 1974 Dec 11;48(60):2508A–2508D. [PubMed] [Google Scholar]
  42. Wild C. P., Jiang Y. Z., Allen S. J., Jansen L. A., Hall A. J., Montesano R. Aflatoxin-albumin adducts in human sera from different regions of the world. Carcinogenesis. 1990 Dec;11(12):2271–2274. doi: 10.1093/carcin/11.12.2271. [DOI] [PubMed] [Google Scholar]
  43. Wild C. P., Jiang Y. Z., Sabbioni G., Chapot B., Montesano R. Evaluation of methods for quantitation of aflatoxin-albumin adducts and their application to human exposure assessment. Cancer Res. 1990 Jan 15;50(2):245–251. [PubMed] [Google Scholar]

Articles from Environmental Health Perspectives are provided here courtesy of National Institute of Environmental Health Sciences

RESOURCES